Collectively, our results delineate a novel IF1/ESR1/miR-20a-3p/GNAZ pathway regulating VM in HCC, highlighting IF1 as a potential therapeutic target for suppressing VM-mediated metastasis. This evidence concerns the gene GNAZ and hepatocellular carcinoma.